Cargando…

Gene Expression of Endothelin-1 and Endothelin Receptor A on Monocrotaline-Induced Pulmonary Hypertension in Rats After Bosentan Treatment

BACKGROUND AND OBJECTIVES: Endothelin (ET)-1, a potent endothelium-derived vasoconstrictor peptide, has a potential pathophysiologic role in pulmonary hypertension. Bosentan, a dual ET receptor (ET(A)/ET(B)) antagonist, is efficacious in treatment of pulmonary hypertension. The objectives of this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Kyoung Ah, Kim, Kwan Chang, Cho, Min-Sun, Lee, Bo En, Kim, Hae Soon, Hong, Young Mi
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957645/ https://www.ncbi.nlm.nih.gov/pubmed/20967148 http://dx.doi.org/10.4070/kcj.2010.40.9.459

Ejemplares similares

Effect of Small Hairpin RNA Targeting Endothelin-Converting Enzyme-1 in Monocrotaline-Induced Pulmonary Hypertensive Rats
por: Son, Jae Sung, et al.
Publicado: (2012)

Transforming growth factor-β inhibition and endothelin receptor blockade in rats with monocrotaline-induced pulmonary hypertension
por: Megalou, Aikaterini J., et al.
Publicado: (2012)

Apoptosis and Inflammation Associated Gene Expressions in Monocrotaline-Induced Pulmonary Hypertensive Rats after Bosentan Treatment
por: Hong, Young Mi, et al.
Publicado: (2014)

Effect of Ambrisentan Therapy on the Expression of Endothelin Receptor, Endothelial Nitric Oxide Synthase and NADPH Oxidase 4 in Monocrotaline-induced Pulmonary Arterial Hypertension Rat Model
por: Lee, Hyeryon, et al.
Publicado: (2019)

Gene Expressions of Nitric Oxide Synthase and Matrix Metalloproteinase-2 in Monocrotaline-Induced Pulmonary Hypertension in Rats After Bosentan Treatment
por: Koo, Hee Sun, et al.
Publicado: (2011)

Role of Endothelin-1 in Right Atrial Arrhythmogenesis in Rabbits with Monocrotaline-Induced Pulmonary Arterial Hypertension
por: Lu, Yen-Yu, et al.
Publicado: (2022)

Pipersentan: A De Novo Synthetic Endothelin Receptor Antagonist that Inhibits Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension
por: Zhang, Zeyu, et al.
Publicado: (2022)

Role of endothelin receptor antagonist; bosentan in cisplatin-induced nephrotoxicity in ovariectomized estradiol treated rats
por: Zahedi, Alieh, et al.
Publicado: (2015)

Insights into Endothelin Receptors in Pulmonary Hypertension
por: Liu, Ruiqi, et al.
Publicado: (2023)

Metformin prevents the development of monocrotaline-induced pulmonary hypertension by decreasing serum levels of big endothelin-1
por: Yoshida, Tomohiko, et al.
Publicado: (2020)

Monocrotaline-Induced Pulmonary Arterial Hypertension and Bosentan Treatment in Rats: Focus on Plasma and Erythrocyte Parameters
por: Jasenovec, Tomas, et al.
Publicado: (2022)

Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice
por: Imhof, Anne-Katja, et al.
Publicado: (2011)

The efficiency of endothelin receptor antagonist bosentan for pulmonary arterial hypertension associated with congenital heart disease: A systematic review and meta-analysis
por: Kuang, Hong-Yu, et al.
Publicado: (2018)

A non-selective endothelin receptor antagonist bosentan modulates kinetics of bone marrow-derived cells in ameliorating pulmonary hypertension in mice
por: Kato, Taichi, et al.
Publicado: (2020)

Combined use of ursodeoxycholic acid and bosentan prevents liver toxicity caused by endothelin receptor antagonist bosentan monotherapy: two case reports
por: Ito, Tomoki, et al.
Publicado: (2014)

Role of endothelin-1 antagonist; bosentan, against cisplatin-induced nephrotoxicity in male and female rats
por: Jokar, Zahra, et al.
Publicado: (2015)

Cardiopulmonary dysfunction during porcine endotoxin shock is effectively counteracted by the endothelin receptor antagonist bosentan
por: Waneek, M, et al.
Publicado: (1997)

Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension
por: Tabeling, Christoph, et al.
Publicado: (2022)

An inhibitory effect of tumor necrosis factor-alpha antagonist to gene expression in monocrotaline-induced pulmonary hypertensive rats model
por: Kwon, Jung Hyun, et al.
Publicado: (2013)

Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
por: Droste, Annette S, et al.
Publicado: (2009)

Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension
por: Steven, Sebastian, et al.
Publicado: (2017)

Changes of Gene Expression after Bone Marrow Cell Transfusion in Rats with Monocrotaline-Induced Pulmonary Hypertension
por: Kim, Kwan Chang, et al.
Publicado: (2012)

Endotheliitis, endothelin, and endothelin receptor blockers in COVID-19
por: Sanghavi, Devang K., et al.
Publicado: (2021)

The role of endothelin-1 in pulmonary arterial hypertension
por: Chester, Adrian H., et al.
Publicado: (2014)

Effect of the dual endothelin receptor antagonist bosentan on untreatable skin ulcers in a patient with diabetes: a case report
por: Álvarez Reyes, Fátima, et al.
Publicado: (2011)

Expression of Endothelin-1, Endothelin Receptor-A, and Endothelin Receptor-B in facial melasma compared to adjacent skin
por: da Silva, Carolina Nunhez, et al.
Publicado: (2023)

Endothelin-1 gene and endothelin receptor A gene polymorphisms in severe pulmonary hypertension associated with rheumatic mitral valve disease
por: Mehra, Pratishtha, et al.
Publicado: (2022)

Pulmonary vasoreactivity in spontaneously hypertensive rats - Effects of endothelin-1 and leptin
por: Gomart, Samantha, et al.
Publicado: (2014)

Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension
por: Steiner, M Kathryn, et al.
Publicado: (2008)

Endothelin ET(A) receptors predominate in chronic thromboembolic pulmonary hypertension
por: Southwood, Mark, et al.
Publicado: (2016)

Circulating Levels of Endothelin-1 and Big Endothelin-1 in Patients with Essential Hypertension
por: Kostov, Krasimir, et al.
Publicado: (2021)

Evaluation of the Endothelin Receptor Antagonists Ambrisentan, Bosentan, Macitentan, and Sitaxsentan as Hepatobiliary Transporter Inhibitors and Substrates in Sandwich-Cultured Human Hepatocytes
por: Lepist, Eve-Irene, et al.
Publicado: (2014)

Endothelin Receptors and Their Antagonists()()
por: Maguire, Janet J., et al.
Publicado: (2015)

Hypoxic pulmonary vasoconstriction and vascular contractility in monocrotaline-induced pulmonary arterial hypertensive rats
por: Kim, Hae Jin, et al.
Publicado: (2016)

The Role of Endothelin-1 and Endothelin Receptor Antagonists in Inflammatory Response and Sepsis
por: Kowalczyk, Agata, et al.
Publicado: (2014)

Changes of Pulmonary Pathology and Gene Expressions After Simvastatin Treatment in the Monocrotaline-Induced Pulmonary Hypertension Rat Model
por: Lee, Yun Hee, et al.
Publicado: (2011)

Endothelin
por: Davenport, Anthony P., et al.
Publicado: (2016)

Gender differences in genotypic distribution of endothelin-1 gene and endothelin receptor A gene in pulmonary hypertension associated with rheumatic mitral valve disease
por: Mehra, Pratishtha, et al.
Publicado: (2022)

Iontophoresis of Endothelin Receptor Antagonists in Rats and Men
por: Roustit, Matthieu, et al.
Publicado: (2012)

Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?
por: Opitz, Christian F., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_q1vauufgmnl5i0q72b473r8ska